| Unfavorable outcome (n = 47) | Favorable outcome (n = 47) | P value |
---|---|---|---|
Female | 53.2% | 46.8% | 0.54 |
Age | 82.0 ± 7.8 | 80.7 ± 9.6 | 0.49 |
White race | 94% | 100% | 0.08 |
Diabetes | 45% | 30% | 0.14 |
Systemic steroids | 11% | 8.5% | 0.73 |
Other immunosuppression | 6.4% | 4.2% | 0.65 |
BMIa | 28.8 ± 8.1 | 28.1 ± 6.9 | 0.64 |
Smoking status | Â | Â | 0.71 |
 Current | 2.1% | 4.3% |  |
 Former | 57.4% | 60.0% |  |
 Never | 38.3% | 36.2% |  |
Reason for TAVR | Â | Â | 0.16 |
 Inoperable/extreme risk | 12.7% | 2.1% |  |
 High risk | 61.7% | 72.3% |  |
 Intermediate risk | 19.1% | 23.4% |  |
 Other | 6.4% | 2.1% |  |
Gait speed | Â | Â | Â |
 Unable to walk | 2% | 17% | 0.01 |
 5 M walk speed (s) | 9.4 ± 0.67 | 8.3 ± 4.4 | 0.69 |
Grip strength | Â | Â | Â |
 Men (kg) | 25.6 ± 6.6 | 28.3 ± 10.7 | 0.31 |
 Women (kg) | 14.3 ± 6.4 | 14.7 ± 4.7 | 0.79 |
Baseline KCCQb score | 45.2 ± 18.5 | 49.8 ± 20.6 | 0.54 |
STSc score | 5.4 ± 3.4 | 4.8 ± 3.2 | 0.34 |
Columbia Frailty score | 5.0 ± 2.6 | 5.1 ± 3.2 | 0.85 |